vs
ACUITY INC. (DE)（AYI）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
ACUITY INC. (DE)的季度营收约是Revvity的1.5倍（$1.1B vs $772.1M），Revvity净利率更高（12.7% vs 10.5%，领先2.2%），ACUITY INC. (DE)同比增速更快（20.2% vs 5.9%），Revvity自由现金流更多（$161.8M vs $114.8M），过去两年ACUITY INC. (DE)的营收复合增速更高（12.4% vs 9.0%）
Squarespace是总部位于美国纽约的网站搭建与托管服务商，以SaaS模式提供一站式网站建设及托管服务，用户可借助平台预置的模板和拖拽式组件，无需专业代码能力即可快速创建、调整网页内容。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
AYI vs RVTY — 直观对比
营收规模更大
AYI
是对方的1.5倍
$772.1M
营收增速更快
AYI
高出14.3%
5.9%
净利率更高
RVTY
高出2.2%
10.5%
自由现金流更多
RVTY
多$47.0M
$114.8M
两年增速更快
AYI
近两年复合增速
9.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $772.1M |
| 净利润 | $120.5M | $98.4M |
| 毛利率 | 48.4% | — |
| 营业利润率 | 14.0% | 14.5% |
| 净利率 | 10.5% | 12.7% |
| 营收同比 | 20.2% | 5.9% |
| 净利润同比 | 12.9% | 3.9% |
| 每股收益（稀释后） | $3.82 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AYIRVTY
| Q4 25 | $1.1B | $772.1M | ||
| Q3 25 | $1.2B | $698.9M | ||
| Q2 25 | $1.2B | $720.3M | ||
| Q1 25 | $1.0B | $664.8M | ||
| Q4 24 | $951.6M | $729.4M | ||
| Q3 24 | $1.0B | $684.0M | ||
| Q2 24 | $968.1M | $691.7M | ||
| Q1 24 | $905.9M | $649.9M |
净利润AYIRVTY
| Q4 25 | $120.5M | $98.4M | ||
| Q3 25 | $114.0M | $46.7M | ||
| Q2 25 | $98.4M | $53.9M | ||
| Q1 25 | $77.5M | $42.2M | ||
| Q4 24 | $106.7M | $94.6M | ||
| Q3 24 | $118.9M | $94.4M | ||
| Q2 24 | $113.9M | $55.4M | ||
| Q1 24 | $89.2M | $26.0M |
毛利率AYIRVTY
| Q4 25 | 48.4% | — | ||
| Q3 25 | 48.9% | 53.6% | ||
| Q2 25 | 48.4% | 54.5% | ||
| Q1 25 | 46.5% | 56.5% | ||
| Q4 24 | 47.2% | — | ||
| Q3 24 | 47.3% | 56.3% | ||
| Q2 24 | 46.7% | 55.7% | ||
| Q1 24 | 45.5% | 54.6% |
营业利润率AYIRVTY
| Q4 25 | 14.0% | 14.5% | ||
| Q3 25 | 14.9% | 11.7% | ||
| Q2 25 | 11.9% | 12.6% | ||
| Q1 25 | 11.0% | 10.9% | ||
| Q4 24 | 14.0% | 16.3% | ||
| Q3 24 | 15.2% | 14.3% | ||
| Q2 24 | 15.0% | 12.4% | ||
| Q1 24 | 13.0% | 6.8% |
净利率AYIRVTY
| Q4 25 | 10.5% | 12.7% | ||
| Q3 25 | 9.4% | 6.7% | ||
| Q2 25 | 8.3% | 7.5% | ||
| Q1 25 | 7.7% | 6.4% | ||
| Q4 24 | 11.2% | 13.0% | ||
| Q3 24 | 11.5% | 13.8% | ||
| Q2 24 | 11.8% | 8.0% | ||
| Q1 24 | 9.8% | 4.0% |
每股收益（稀释后）AYIRVTY
| Q4 25 | $3.82 | $0.86 | ||
| Q3 25 | $3.61 | $0.40 | ||
| Q2 25 | $3.12 | $0.46 | ||
| Q1 25 | $2.45 | $0.35 | ||
| Q4 24 | $3.35 | $0.77 | ||
| Q3 24 | $3.77 | $0.77 | ||
| Q2 24 | $3.62 | $0.45 | ||
| Q1 24 | $2.84 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $376.1M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.8B | $7.3B |
| 总资产 | $4.7B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AYIRVTY
| Q4 25 | $376.1M | $919.9M | ||
| Q3 25 | $422.5M | $931.4M | ||
| Q2 25 | $371.8M | $991.8M | ||
| Q1 25 | $397.9M | $1.1B | ||
| Q4 24 | $935.6M | $1.2B | ||
| Q3 24 | $845.8M | $1.2B | ||
| Q2 24 | $699.0M | $2.0B | ||
| Q1 24 | $578.9M | $1.7B |
股东权益AYIRVTY
| Q4 25 | $2.8B | $7.3B | ||
| Q3 25 | $2.7B | $7.4B | ||
| Q2 25 | $2.6B | $7.6B | ||
| Q1 25 | $2.5B | $7.6B | ||
| Q4 24 | $2.5B | $7.7B | ||
| Q3 24 | $2.4B | $7.9B | ||
| Q2 24 | $2.3B | $7.9B | ||
| Q1 24 | $2.1B | $7.8B |
总资产AYIRVTY
| Q4 25 | $4.7B | $12.2B | ||
| Q3 25 | $4.8B | $12.1B | ||
| Q2 25 | $4.6B | $12.4B | ||
| Q1 25 | $4.6B | $12.4B | ||
| Q4 24 | $3.9B | $12.4B | ||
| Q3 24 | $3.8B | $12.8B | ||
| Q2 24 | $3.6B | $13.4B | ||
| Q1 24 | $3.5B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $140.8M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $114.8M | $161.8M |
| 自由现金流率自由现金流/营收 | 10.0% | 21.0% |
| 资本支出强度资本支出/营收 | 2.3% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.17× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $534.5M | $509.4M |
8季度趋势，按日历期对齐
经营现金流AYIRVTY
| Q4 25 | $140.8M | $182.0M | ||
| Q3 25 | $202.5M | $138.5M | ||
| Q2 25 | $207.3M | $134.3M | ||
| Q1 25 | $59.4M | $128.2M | ||
| Q4 24 | $132.2M | $174.2M | ||
| Q3 24 | $174.1M | $147.9M | ||
| Q2 24 | $152.5M | $158.6M | ||
| Q1 24 | $102.6M | $147.6M |
自由现金流AYIRVTY
| Q4 25 | $114.8M | $161.8M | ||
| Q3 25 | $177.7M | $120.0M | ||
| Q2 25 | $192.3M | $115.5M | ||
| Q1 25 | $49.7M | $112.2M | ||
| Q4 24 | $113.3M | $149.8M | ||
| Q3 24 | $151.1M | $125.6M | ||
| Q2 24 | $140.5M | $136.6M | ||
| Q1 24 | $88.2M | $129.7M |
自由现金流率AYIRVTY
| Q4 25 | 10.0% | 21.0% | ||
| Q3 25 | 14.7% | 17.2% | ||
| Q2 25 | 16.3% | 16.0% | ||
| Q1 25 | 4.9% | 16.9% | ||
| Q4 24 | 11.9% | 20.5% | ||
| Q3 24 | 14.6% | 18.4% | ||
| Q2 24 | 14.5% | 19.7% | ||
| Q1 24 | 9.7% | 20.0% |
资本支出强度AYIRVTY
| Q4 25 | 2.3% | 2.6% | ||
| Q3 25 | 2.1% | 2.6% | ||
| Q2 25 | 1.3% | 2.6% | ||
| Q1 25 | 1.0% | 2.4% | ||
| Q4 24 | 2.0% | 3.4% | ||
| Q3 24 | 2.2% | 3.3% | ||
| Q2 24 | 1.2% | 3.2% | ||
| Q1 24 | 1.6% | 2.7% |
现金转化率AYIRVTY
| Q4 25 | 1.17× | 1.85× | ||
| Q3 25 | 1.78× | 2.97× | ||
| Q2 25 | 2.11× | 2.49× | ||
| Q1 25 | 0.77× | 3.03× | ||
| Q4 24 | 1.24× | 1.84× | ||
| Q3 24 | 1.46× | 1.57× | ||
| Q2 24 | 1.34× | 2.87× | ||
| Q1 24 | 1.15× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AYI
| Sales Channel Through Independent Sales Network | $616.7M | 54% |
| Acuity Intelligent Spaces | $248.1M | 22% |
| QSCLLC | $95.1M | 8% |
| Sales Channel Through Direct Sales Network | $70.6M | 6% |
| Sales Channel Through Original Equipment Manufacturer And Other | $49.1M | 4% |
| Sales Channel Through Corporate Accounts Network | $40.7M | 4% |
| Sales Channel Through Retail | $40.3M | 4% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
